Gold nanoparticle aggregates (red) are observed inside triple negative breast cancer cells after an enzyme-activated assembly and internalization process.
(photo credit: Richard Huang and Ye He)
The breakthrough advance could lead to a novel, drug-free therapeutic that can slow, possibly stop, the growth of cancer cells
A multi-institutional research team has designed nanoparticles that can communicate with and slow the development of cancer cells. The work — detailed in a newly published paper in Advanced Materials — has uncovered a novel framework for the potential development of drug-free cancer therapies.
Led by scientists at the Advanced Science Research Center at the Graduate Center, CUNY (CUNY ASRC), the research team was able to design nanoparticles that are activated to self-assemble when they encounter cancer cells and send messages to instruct the cells to slow their growth. Because the nanoparticles communicate only with the cancer cells, the surrounding healthy cells aren’t impacted.
“Cancer cells take up materials from their environment, and they also secrete factors that help them degrade surrounding tissue in order to spread and metastasize,” said Richard Huang, lead author of the paper, a Ph.D. student at the Graduate Center, CUNY (GC CUNY), and a researcher with the CUNY ASRC Nanoscience Initiative and the Center for Discovery and Innovation at CUNY’s City College of New York (CCNY). “We made particles that respond to both of these characteristics by aggregating into clusters that are actively taken up by cancer cells. Once inside, they appear to be able to reduce the cancer cells’ metabolic activity and consequently reduce their growth.
One reason the progression of cancer is difficult to control is that the cells secrete an abnormally large amount of the matrix metalloproteinase-9 (MMP-9) enzyme, which breaks down the collagen that holds together healthy tissue. The research team was able to use this feature against the cancer cells. This is achieved by designing nanoparticles that when triggered by MMP-9, begin assembling to large aggregates in the cells’ vicinity. The cells engulf these aggregates, and their size causes physical distress to the cancer cells and reduces their ability to proliferate and survive.
One highlight of the study is that the researchers were able to use confocal reflection microscopy to visualize the nanoparticle aggregates inside the cancer cells in real-time. “This label-free, live imaging technique allowed us to have a closer look at when and where the aggregates were formed, and how the cancer cells respond to the particles at the sub-cellular level,” said Ye He, director of the Live Imaging and Bioenergetics Facility in the CUNY ASRC Neuroscience Initiative.
“Through this research, we wanted to determine whether it’s possible to make use of relatively simple peptide design to create nanoparticles that could produce robust self-assembly in biological media and have an impact on cancer cells,” said Rein Ulijn, director of the CUNY ASRC Nanoscience Initiative and the study’s principal investigator. “While this is early-stage research, the findings provide exciting possibilities for a drug-free therapeutic treatment that could be extremely useful for cancer patients who have developed drug resistance and for extending the lives of people with metastatic cancer.”
Further studies are needed to fully access the therapeutic potential of the team’s discovery.
Original Article: Scientists Design Nanoparticles That Communicate With Cancer Cells
More from: City University of New York | University of Strathclyde | Weizmann Institute of Science
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Self-assembling nanoparticles
- Scientists develop nanoparticle-based biosensing device for rapid and ultrasensitive detection of SARS-CoV-2
Researchers developed a gold nanoparticle-based biosensing device for rapid and ultrasensitive detection of SARS-CoV-2 in point-of-care settings.
- Aalto University: New nanoparticle-based material could help detect antibiotics in water
An international team of researchers has developed a new type of strong and elastic two-dimensional (2D) membrane. The invention could prove useful, for instance, in detecting remnants of antibiotics ...
- Significant Step in Forming Self-Sustained Smart Nanosystems
The DNA-functionalized nanoparticles assembly, induced by heating or light excitation caused ... The present study is an important contribution to self-sustained, environment-activatable, intelligent ...
- New nanoparticle-based material could detect antibiotics in water
An international team of researchers has developed a new type of strong and elastic two-dimensional (2D) membrane. The invention could prove useful, for instance, in detecting remnants of antibiotics ...
- New nanoparticle-based material could help detect antibiotics in water
Recently, nanoparticle-based 2D materials have gained tremendous interest among researchers and industry due to their mechanical strength, flexibility, and optical and electronic properties which ...
Go deeper with Google Headlines on:
Self-assembling nanoparticles
Go deeper with Bing News on:
Drug-free cancer treatment
- FDA OKs First Targeted Drug for HER2-Low Breast Cancer
The FDA has approved the first targeted therapy for unresectable/metastatic breast cancer in the newly defined low-HER2 subtype. The approval for trastuzumab deruxtecan (T-DXd, Enhertu) recognizes the ...
- FDA Approves First Targeted Drug to Treat HER2 Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)
ASCO meeting, MSK medical oncologist Shanu Modi is presenting results from a clinical trial that found more people can benefit from a targeted therapy for breast cancer than previously thought.
- New study using VR technology hopes to make cancer treatment for kids less stressful
A new study at Lawson Health Research Institute and Children’s Hospital at London Health Sciences Centre (LHSC) is using virtual reality (VR) to minimize fear and anxiety in pediatric patients during ...
- AstraZeneca Lynparza Breast Cancer Treatment Approved for Use in EU
By Joe Hoppe AstraZeneca PLC said Thursday that its Lynparza treatment has been approved in the European Union for patients with early breast cancer.
- 2 more people have been 'cured' of HIV — 1 man thanks to cancer treatment, and 1 woman who mysteriously developed natural control over the virus
Two more patients were announced functionally "cured" of HIV during AIDS 2022. One had cancer, the other has naturally controlled the virus for years.